27045 Excision, tumor, soft tissue of pelvis and hip area, subfascial (eg, intramuscular); 5 cm or greater

Name of the Procedure:

Excision of a tumor in the soft tissue of the pelvis and hip area, subfascial (intramuscular); 5 cm or greater. Commonly referred to as "Subfascial Tumor Excision in the Pelvis/Hip Area."

Summary

In this procedure, a surgeon removes a tumor from the soft tissues located beneath the fascia (connective tissue) and within the muscles of the pelvis and hip region. The tumor being removed is 5 centimeters or greater in size.

Purpose

Medical Condition

• Removal of benign or malignant tumors located in the soft tissues of the pelvis and hip area. ##### Goals
• Eliminate or reduce tumor size.
• Alleviate symptoms such as pain, discomfort, or impaired function.
• Prevent tumor growth or spread (in case of malignancy).

Indications

Symptoms/Conditions

• Detectable mass or lump in the pelvis/hip area.
• Chronic pain or discomfort in the affected region.
• Impaired mobility or function.
• Imaging or biopsy results indicating a tumor. ##### Patient Criteria
• Tumor size of 5 cm or greater.
• Tumor located beneath the fascia and within the muscle layers.
• Patient medically fit for surgery.

Preparation

• Fasting for at least 8 hours prior to the procedure.
• Discontinue certain medications (as advised by the physician).
• Preoperative imaging (MRI, CT scan) to localize the tumor.
• Blood tests to assess general health status.

Procedure Description

1. The patient is placed under general anesthesia.
2. A surgical incision is made over the tumor site.
3. The surgeon carefully dissects through the soft tissue to reach the tumor.
4. The tumor is excised with a margin of healthy tissue to ensure complete removal.
5. The surgical site is thoroughly inspected for any remaining tumor tissue.
6. The incision is closed using sutures or staples. ##### Tools and Technology
   • Scalpels, retractors, and surgical scissors.
   • Imaging guidance equipment (if necessary).
   • Anesthesia machines and monitoring devices.

Duration

The procedure typically lasts between 1 to 3 hours, depending on the tumor size and complexity.

Setting

• Hospital operating room or surgical center.

Personnel

• A surgical team including the main surgeon, surgical assistants, anesthesiologist, and operating room nurses.

Risks and Complications

Common Risks

• Infection at the surgical site.
• Bleeding or hematoma formation. ##### Rare Complications
• Damage to surrounding muscles or nerves.
• Blood clots.
• Adverse reaction to anesthesia.

Benefits

Expected Benefits

• Removal of the tumor.
• Relief from associated symptoms.
• Potentially improved function and mobility. ##### Realization of Benefits
• Benefits are typically noticeable within weeks after recovery.

Recovery

• Hospital stay for 1 to 2 days for monitoring.
• Pain management with prescribed medications.
• Rest and limited physical activity for a few weeks.
• Follow-up appointments to monitor healing and check for recurrence.
• Physical therapy might be recommended to regain strength and mobility.

Alternatives

Treatment Options

• Radiation therapy.
• Chemotherapy (for malignant tumors).
• Less invasive procedures (if suitable). ##### Pros and Cons
• Radiation and chemotherapy may avoid surgery but might not be effective for all tumors.
• Less invasive methods may be insufficient for large or deep-seated tumors.

Patient Experience

• Pre-procedure anxiety managed by the healthcare team.
• General anesthesia will render the patient unconscious during surgery, so no pain is felt.
• Postoperative pain managed with medications.
• Possible discomfort and limited mobility immediately after surgery.
• Gradual improvement in symptoms as healing progresses.